Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
amyvid
Synonyms :
Florbetapir F18
Class :
Diagnostic imaging agent
Dosage Forms & StrengthsÂ
IntravenousÂ
0.1-19mcg/ml and 13.5-51mCi/ml (florbetapir and florbetapir F 18)Â
Beta-amyloid Plaque EstimationÂ
370MBq in 10ml solution for injection at the time of administration, followed by 0.9% NaCl with an IV flush of 10ml. Do not exceed 50mcg
Image Display And InterpretationÂ
After 30-50 mins of IV infection,10 minutes of PET image should be acquired
sulopenem etzadroxil/probenecid
It may enhance the risk of adverse effects when combined with Diagnostic agents
sulopenem (Pending FDA Approval)
It may enhance the risk of adverse effects when combined with Diagnostic agents
It may enhance the risk of adverse effects when combined with Diagnostic agents
It may enhance the risk of adverse effects when combined with Diagnostic agents
It may enhance the risk of adverse effects when combined with Diagnostic agents
Frequency defined:Â Â
1-10%Â
HeadacheÂ
<1%Â
FatigueÂ
AnxietyÂ
Increased blood pressureÂ
Feeling coldÂ
Neck painÂ
Musculoskeletal painÂ
NauseaÂ
Back painÂ
ClaustrophobiaÂ
Pregnancy consideration: Insufficient data availableÂ
Lactation: Excretion of the drug in human breast milk is unknownÂ
Pregnancy category:Â
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.  Â
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.   Â
Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.   Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.   Â
Category N: There is no data available for the drug under this categoryÂ
Patient information leafletÂ
Generic Name: Florbetapir F18Â
Pronounced: flor-BET-a-pir Â
Why do we use Florbetapir F18?Â
It is used to determine the reasons for cognitive impairment in adult patients; it is done during Positron Emission Tomography (PET) imaging of the brainÂ